Get the Stockscreener App
51.10
3.00%
-1.58
After Hours:
51.15
0.05
+0.10%
Tempus Ai Inc stock is traded at $51.10, with a volume of 3.18M.
It is down -3.00% in the last 24 hours and up +19.90% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$52.68
Open:
$51.41
24h Volume:
3.18M
Relative Volume:
0.60
Market Cap:
$9.17B
Revenue:
$1.27B
Net Income/Loss:
$-245.03M
P/E Ratio:
-36.32
EPS:
-1.4071
Net Cash Flow:
$-245.36M
1W Performance:
-7.34%
1M Performance:
+19.90%
6M Performance:
-40.99%
1Y Performance:
-4.97%
1-Day Range:
$50.38
$51.91
1-Week Range:
$50.03
$57.40
52-Week Range:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
51.10 | 9.45B | 1.27B | -245.03M | -245.36M | -1.4071 |
VEEV
Veeva Systems Inc
|
158.49 | 26.21B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
47.49 | 9.38B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
81.18 | 7.06B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
25.23 | 4.93B | 1.10B | 112.09M | 283.19M | 0.6096 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Jefferies | Underperform |
| Apr-13-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026 - The Joplin Globe
Artificial Intelligence Stocks Worth WatchingApril 27th - MarketBeat
Tempus AI will acquire Paige for $81.25M - MSN
Tempus AI, Inc. $TEM Stake Cut by Renaissance Capital LLC - MarketBeat
Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy? - Zacks Investment Research
What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum? - MSN
Artificial Intelligence Stocks To ConsiderApril 26th - MarketBeat
Can Tempus AI’s (TEM) USC Partnership Quietly Redefine Its Clinical Data Moat? - simplywall.st
Best Artificial Intelligence Stocks To Watch NowApril 25th - MarketBeat
TEM Stock Quote Price and Forecast - CNN
Tempus AI Nears Profitability as Operating Leverage Emerges - The Globe and Mail
Artificial Intelligence Stocks To Watch NowApril 24th - MarketBeat
Tempus AI Stock Faces a New Test as USC Deal Opens a 1.5 Million-Visit Door - TechStock²
Tempus AI (TEM) Stock Drops 7% Despite Landmark USC Medical Partnership - MEXC Exchange
Tempus AI (TEM) Stock Slides Even As USC Inks Major AI Health Deal - MEXC
Artificial Intelligence Clinical Trial Protocol Feasibility Tool Research Report 2026: $2.75+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035F - GlobeNewswire Inc.
Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Volatility? - Yahoo Finance
Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine - BioSpace
Tempus AI shares gain after expanded partnership with Gilead - msn.com
Tempus AI Stock Falls After USC Deal, Putting Its Cancer Data Push To The Test - TechStock²
Healthcare AI Firm Sued Over Alleged Unlawful Disclosures of Genetic Data - The HIPAA Journal
Median Technologies Reports Full-Year 2025 Financial Results and Provides Key Q1 2026 Business Highlights - PharmiWeb.com
Promising Artificial Intelligence Stocks To Add to Your WatchlistApril 23rd - MarketBeat
USC and Tempus AI partner to advance precision medicine - News-Medical
FDA clears AI lung cancer tool; first U.S. sites set for Q3 - Stock Titan
Cathie Wood Is Loading Up on These 3 Next-Gen Tech Stocks - Yahoo Finance
USC and Tempus Join Forces in Strategic Partnership to Accelerate Innovation in Research and Patient Care - Bioengineer.org
Tempus AI partners with USC’s Keck Medicine on precision care - Investing.com
TEM (Tempus AI Inc.) tops EPS estimates and posts 83 percent year over year revenue growth, shares fall 3.53 percent today.Crowd Risk Alerts - Xã Thanh Hà
Is Tempus AI (TEM) Pricing Reflect Its DCF Upside And Premium Sales Multiple - simplywall.st
Promising Artificial Intelligence Stocks To Keep An Eye OnApril 21st - MarketBeat
Tempus AI Inc. (TEM): Nancy Pelosi Likes This AI-Powered Medicine Company - Insider Monkey
Hims & Hers Builds Scalable Data-Driven Personalized Care Platform - TradingView
Tempus to Report First Quarter 2026 Financial Results on May 5 - BioSpace
Press Release: Tempus to Report First Quarter 2026 Financial Results on May 5 - Moomoo
Tempus AI (TEM) Stock: Growth Outlook (On the Radar) 2026-04-20High Interest Stocks - Xã Thanh Hà
Artificial Intelligence Stocks To Add to Your WatchlistApril 20th - MarketBeat
Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 29.59% Potential Upside in the Healthcare Information Sector - DirectorsTalk Interviews
Tempus AI, Inc. (NASDAQ:TEM) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Tempus AI stock gains following the ALERT trial result announcement - MSN
Gilead (GILD), Tempus AI (TEM) expand multi-year oncology R&D collaboration - MSN
Here’s What TD Cowen Thinks About Tempus AI Inc (TEM) Stock - Insider Monkey
Best Artificial Intelligence Stocks Worth WatchingApril 19th - MarketBeat
Promising Artificial Intelligence Stocks To Watch TodayApril 18th - MarketBeat
Tempus AI stock near 1-year low: Cathie Wood’s ARK buys more while offloading Nvidia, Meta, other tech plays - MSN
Artificial Intelligence Stocks To Follow NowApril 17th - MarketBeat
Tempus AI (NASDAQ:TEM) Shares Down 5.2%Should You Sell? - MarketBeat
Tempus AI Expands Strategic Partnership Amid Oncology Boom - TradingView
A Look At Tempus AI (TEM) Valuation After GenoPredicta Collaboration And AACR 2026 Cancer Diagnostics Updates - Yahoo Finance
Could Tempus AI’s GenoPredicta Data Push Quietly Reshape Its Precision Oncology Edge (TEM)? - Yahoo Finance
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.22%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):